Recursos del Paciente
Manténgase sano!
Resultados de su búsqueda "Diabetes: Drugs".
Resultados de noticias de salud - 33
Wegovy Helps Those With Both Diabetes, Heart Failure: Study
- Robin Foster HealthDay Reporter
- April 9, 2024
- Página completa
For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests.
FDA Clears First OTC Continuous Blood Glucose Monitor
- Robin Foster HealthDay Reporter
- March 6, 2024
- Página completa
The U.S. Food and Drug Administration on Tuesday approved the country's first continuous glucose monitor for type 2 diabetes.
The new Dexcom Stelo Glucose Biosensor System, which will be available by summer, is intended for people 18 and older who have type 2 diabetes bu...
FDA Looking Into New Risks With Popular Weight-Loss Drugs
- Robin Foster HealthDay Reporter
- January 4, 2024
- Página completa
The U.S. Food and Drug Administration is investigating reports of additional dangers linked to several wildly popular weight-loss drugs.
More Americans Will Only Have to Pay $35 a Month for Insulin in 2024
- Robin Foster HealthDay Reporter
- January 2, 2024
- Página completa
Managing diabetes will be a less expensive proposition for more Americans in 2024.
Sanofi has officially joined Novo Nordisk and Eli Lilly in lowering the cost of insulin t...
Newer Diabetes Meds Might Not Work as Well in Black Patients
- Cara Murez HealthDay Reporter
- September 22, 2023
- Página completa
New research suggests some newer diabetes treatments may not be as beneficial for Black patients, after earlier drug trials included small numbers of non-white people.
Whether the medications -- called sodium-glucose co-transporter 2 inhibitors (SGLT2-Is) and glucogen-li...
Diabetes Drug Maker Sues Over Compounded Versions of Mounjaro
- Cara Murez HealthDay Reporter
- September 20, 2023
- Página completa
Another diabetes drug maker is taking legal action against businesses in several states, alleging that they're "fraudulently claiming"that their compounded products are the same as its medication.
This time, it's Eli Lilly suing certain medical spas, wellness centers and...
Amid Shortages, Maker Says Restrictions on Wegovy Will Continue Into 2024
- Cara Murez HealthDay Reporter
- August 11, 2023
- Página completa
As demand for the wildly popular weight-loss drug Wegovy continues to climb, drug maker Novo Nordisk said Thursday that it will continue restrictions on starter doses of the medication into 2024.
The new plan extends by months existing restrictions and means patients who...
Could Metformin Help Seniors Bounce Back After Surgery?
- Steven Reinberg HealthDay Reporter
- July 28, 2023
- Página completa
The diabetes drug metformin might also benefit older patients after an injury or illness, a small study suggests.
Researchers found that metformin -- a drug that has been around for more than a half-century to regulate blood sugar -- may have a different ability: It can ...
Weekly Insulin Shot Could Be a Game Changer for Those With Type 2 Diabetes
- Dennis Thompson HealthDay Reporter
- July 17, 2023
- Página completa
People with type 2 diabetes could soon have access to convenient once-a-week insulin shots that could replace the daily injections now required.
A once-weekly insulin formulation called icodec performed just as well as daily doses of the insulin degludec, phase 3 clinica...
Diabetes Medications: Choosing Which Ones Are Best for You
- Susan E. Spratt, MD Associate Professor of Medicine, Duke University School of Medicine HealthDay Reporter
- July 5, 2023
- Página completa
You have been diagnosed with type 2 diabetes. What are your medication options?
That depends on what type of diabetes you have and what risk factors you carry.
In type 2 diabetes, the body becomes resistant to the insulin and the pancreas has to make more. Insulin ...
Taking Ozempic, Wegovy? Stop Before Surgery, Anesthesiologists Say
- Dennis Thompson HealthDay Reporter
- July 3, 2023
- Página completa
The trendy weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia for an operation, according to a new warning from the American Society of Anesthesiologists.
Semaglutide (Ozempic, Wegovy) and other drugs of their class known as GLP-1 receptor ag...
New Drugs Line Up to Challenge Ozempic, Wegovy for Weight Loss
- Ernie Mundell HealthDay Reporter
- June 26, 2023
- Página completa
After drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy -- a formulation expressly designed to help users shed pounds -- sales of both drugs skyrocketed.
Other pharmaceutical giants took notice, and over the past weekend the results of multiple clinica...
Novo Nordisk Moves to Stop Businesses From Selling Compounded Versions of Wegovy, Ozempic
- Cara Murez HealthDay Reporter
- June 21, 2023
- Página completa
The maker of three popular drugs that treat weight loss and diabetes said Tuesday that it has begun legal proceedings against businesses that are selling compounded versions of its products that are not approved by the U.S. Food and Drug Administration.
Diabetes Med Metformin Might Help Prevent Long COVID
- Dennis Thompson HealthDay Reporter
- June 9, 2023
- Página completa
A safe, generic diabetes pill can help people avoid long COVID, a new clinical trial shows.
Metformin cut the risk of long COVID by about 40% for patients who received a two-week course of the drug while battling their infection, the researchers reported.
The ...
Head-to-Head Study Finds Which Diabetes Meds Are Best for the Heart
- Amy Norton HealthDay Reporter
- May 9, 2023
- Página completa
There are many medications for type 2 diabetes, but one class may stand out for protecting the heart, a new study suggests.
The study, of thousands of U.S. veterans with diabetes, found that those who added drugs called GLP-1 receptor agonists to their usual regimen were...
Eli Lilly to Slash Insulin Prices, Cap Monthly Out-of-Pocket Costs at $35
- Cara Murez HealthDay Reporter
- March 1, 2023
- Página completa
More Americans will soon be paying less for their insulin.
Eli Lilly, one of the three insulin manufacturers, plans to cut its list prices of the drug by 70% and cap out-of-pocket costs at $35 a month.
"While the current health care system provides access to insuli...
Too Few Americans With Diabetes Are Getting Recommended Meds
- Amy Norton HealthDay Reporter
- February 28, 2023
- Página completa
Most Americans with type 2 diabetes are candidates for newer, pricey medications, but few are getting them, a new government study shows.
Researchers found that of U.S. adults with the blood sugar disease, over 80% could stand to benefit from the medications, based on re...
Type 1 Diabetes and Use of 'Off-Label' Drugs: Benefits, but Concerns, Too
- Cara Murez HealthDay Reporter
- February 20, 2023
- Página completa
While people with type 1 diabetes can see some benefit from newer medications prescribed off-label, there is also risk, and these patients should be monitored closely, according to a new study.
Type 1 diabetes is universally treated with insulin injections, but only abou...
Diabetes Med Ozempic in Short Supply as Americans Use It for Weight Loss
- Dennis Thompson HealthDay Reporter
- December 21, 2022
- Página completa
Elon Musk swears by the weight-loss drug Wegovy, and Kim Kardashian is rumored to have used it to shed 16 pounds in three weeks to squeeze into a vintage gown once worn by Marylin Monroe.
But the intense public demand for Wegovy has triggered a shortage of the diabetes v...
Insulin Pumps Ease Diabetes Care. So Why Are Black Patients Less Likely to Get One?
- Denise Mann HealthDay Reporter
- December 13, 2022
- Página completa
Insulin pumps can help folks with type 1 diabetes get better control of their disease and minimize how often they inject insulin, and use of the devices has taken off in the past 20 years.
Cats Now Have an FDA-Approved Pill to Treat Their Diabetes
- Cara Murez HealthDay Reporter
- December 9, 2022
- Página completa
Owners whose cats have diabetes now have a new option to care for the condition in their otherwise healthy pets.
Diabetes Drug Metformin Might Keep Severe COVID Away
- Dennis Thompson HealthDay Reporter
- November 23, 2022
- Página completa
A century-old diabetes drug seems to help keep high-risk COVID-19 patients from falling deathly ill, a new study reports.
Metformin reduced the risk of death from COVI...
California's Plan to Make Low-Priced Insulin Could Be Example for Nation
- Amy Norton HealthDay Reporter
- November 16, 2022
- Página completa
California's plan to manufacture its own insulin could be a huge money-saver for state residents with diabetes -- and possibly be a model for other states, according to experts.
Earlier this year, California announced an initiative to bring its own insulin products to ma...
Certain Class of Diabetes Meds Could Cut Dementia Risk
- Denise Mann HealthDay Reporter
- October 19, 2022
- Página completa
An older class of type 2 diabetes drugs known as thiazolidinediones, or TZDs, may protect you from dementia down the road, according to new research.
Thiazolidinediones, also known as glitazones,...
Over a Million Americans Are Rationing Insulin Due to High Cost
- Amy Norton HealthDay Reporter
- October 18, 2022
- Página completa
More than 1 million Americans with diabetes have to ration lifesaving insulin because they can't afford it, a new study shows.
Many people del...
Big Studies Test Effectiveness of Common Diabetes Meds
- Amy Norton HealthDay Reporter
- September 22, 2022
- Página completa
Two common diabetes medications seem to outperform two others when it comes to controlling blood sugar levels, a large U.S. trial has found.
The trial of more than 5,000 people with type 2 ...
Experimental Insulin-in-a-Pill Shows Promise in Rat Study
- By Cara Murez HealthDay Reporter
- September 5, 2022
- Página completa
People with type 1 diabetes who need to inject insulin a few times a day could eventually be switching to an easier-to-take tablet that dissolves inside the cheek.
Canadian re...
Common Diabetes Drug Januvia May Contain Traces of Carcinogen, FDA Says
- By Cara Murez HealthDay Reporter
- August 12, 2022
- Página completa
The popular diabetes drug Januvia may contain traces of a probable carcinogen, but patients should keep using the medication because it could be dangerous to stop taking it, the U.S. Food and Drug Administration announced this week.
Despite the discovery that Nitroso-ST...
Rise in Birth Defects for Babies Whose Fathers Took Common Diabetes Drug
- Amy Norton
- March 29, 2022
- Página completa
Babies born to fathers who were taking the common diabetes drug metformin may have a slightly increased risk of certain birth defects, a large new study suggests.
Among over 1 million babies...
When Will Americans With Diabetes Get Relief From High Insulin Prices?
- March 14, 2022
- Página completa
Katherine Stewart, 16, must take six to 10 insulin shots a day to properly manage her type 1 diabetes.
Her Highland, Utah, family pays $500 a month out of pocket for her insulin. Before they meet their insurance's deductible, they shell out the cash price of nearly $2,00...
Osteoporosis Drug May Keep Type 2 Diabetes at Bay
- Dennis Thompson HealthDay Reporter
- September 28, 2021
- Página completa
A drug widely used to treat osteoporosis might reduce the risk of type 2 diabetes, a new study suggests.
Taking the drug alendronate (Fosamax) for at least eight years could potentially reduce a person's risk of type 2 diabetes by more than half, compared to people never...
Diabetes Drug Might Help Women With Preeclampsia Prolong Their Pregnancy
- Denise Mann HealthDay Reporter
- September 23, 2021
- Página completa
Metformin, a commonly prescribed diabetes drug, may help stave off preterm birth among women who develop pregnancy-related high blood pressure.
Preeclampsia is marked by a sudden spike in blood pressure, protein in urine, or other problems during pregnancy. Preterm preec...
Some Diabetes Meds Might Also Lower Alzheimer's Risk
- Amy Norton HealthDay Reporter
- August 12, 2021
- Página completa
Older adults who take certain diabetes drugs may see a slower decline in their memory and thinking skills, a new study suggests.
Researchers in South Korea found that among older people who'd been having memory issues, those using diabetes drugs called DDP-4 inhibitors t...